Medifast (MED) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$18.1 million.
- Medifast's Net Income towards Common Stockholders fell 237289.84% to -$18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.7 million, marking a year-over-year decrease of 100591.95%. This contributed to the annual value of -$18.7 million for FY2025, which is 99468.14% down from last year.
- Per Medifast's latest filing, its Net Income towards Common Stockholders stood at -$18.1 million for Q4 2025, which was down 237289.84% from -$2.3 million recorded in Q3 2025.
- Over the past 5 years, Medifast's Net Income towards Common Stockholders peaked at $47.0 million during Q2 2021, and registered a low of -$18.1 million during Q4 2025.
- Over the past 5 years, Medifast's median Net Income towards Common Stockholders value was $24.8 million (recorded in 2022), while the average stood at $19.5 million.
- Data for Medifast's Net Income towards Common Stockholders shows a peak YoY increase of 13036.81% (in 2025) and a maximum YoY decrease of 237289.84% (in 2025) over the last 5 years.
- Medifast's Net Income towards Common Stockholders (Quarter) stood at $34.0 million in 2021, then fell by 22.06% to $26.5 million in 2022, then crashed by 77.24% to $6.0 million in 2023, then crashed by 86.79% to $797000.0 in 2024, then crashed by 2372.9% to -$18.1 million in 2025.
- Its last three reported values are -$18.1 million in Q4 2025, -$2.3 million for Q3 2025, and $2.5 million during Q2 2025.